Andrew J Massey

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 6

Top Topics

High Throughput

Signaling Pathway

Top Venues

Journal of medicinal chemistry

Molecular biomedicine

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew J Massey, Karen Benwell, Mike Burbridge, András Kotschy, David Lee Walmsley
Targeting DYRK1A/B kinases to modulate p21-cyclin D1-p27 signalling and induce anti-tumour activity in a model of human glioblastoma. Journal of cellular and molecular medicine 25 (22) (2021)
David Lee Walmsley, James B Murray, Pawel Dokurno, Andrew J Massey, Karen Benwell, Andrea Fiumana, Nicolas Foloppe, Stuart Ray, Julia Smith, Allan E Surgenor, Thomas Edmonds, Didier Demarles, Mike Burbridge, Francisco Cruzalegui, András Kotschy, Roderick Eliot Hubbard
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B. Journal of medicinal chemistry 64 (13) (2021)
Joanne Wayne, Teresa Brooks, Alexandra Landras, Andrew J Massey
Targeting DNA damage response pathways to activate the STING innate immune signaling pathway in human cancer cells. The FEBS journal 288 (15) (2021)
Csaba Weber, Melinda Sipos, Attila Paczal, Balazs Balint, Vilibald Kun, Nicolas Foloppe, Pawel Dokurno, Andrew J Massey, David Lee Walmsley, Roderick E Hubbard, James B Murray, Karen Benwell, Thomas Edmonds, Didier Demarles, Alain Bruno, Mike Burbridge, Francisco Cruzalegui, András Kotschy
Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors. Journal of medicinal chemistry 64 (10) (2021)
Teresa Brooks, Joanne Wayne, Andrew J Massey
Checkpoint Kinase 1 (Chk1) inhibition fails to activate the Stimulator of Interferon Genes (STING) innate immune signalling in a human coculture cancer system. Molecular biomedicine 2 (1) (2021)
Andrew J Massey
A high content, high throughput cellular thermal stability assay for measuring drug-target engagement in living cells. PloS one 13 (4) (2018)